| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |